Mandate

Vinge advises Nordea and UBS in relation to Sanitec’s listing on NASDAQ OMX Stockholm

November 29, 2013

Vinge advises Nordea Bank AB (publ) and UBS Limited – joint global coordinators and bookrunners – in relation to Sanitec Oyj:s application for listing on NASDAQ OMX Stockholm. Sanitec’s principal shareholder is EQT. A prospectus was published on 27 November and the first day of trading on NASDAQ OMX Stockholm is expected to be 10 December.  

EQT may increase the offer and have also granted, among others, Nordea and UBS a customary over-allotment option. The total value of the offering amounts to approximately SEK 2.4 billion. Assuming the offering is increased in full, the total value of the offering amounts to approximately SEK 3.1 billion (and approximately SEK 3.6 billion assuming the over-allotment option is also exercised in full).  

Sanitec is the market leader in bathroom ceramics and a leading supplier of bathroom fixtures in its core markets (Belgium, Denmark, Finland, France, Germany, Italy, the Netherlands, Norway, Poland, Russia, Sweden, Ukraine, and the United Kingdom). Sanitec has leading positions (number one or two based on volume) in bathroom ceramics in 12 of its 13 core markets and command a strong position in growth markets, including Russia. Sanitec’s unique brand portfolio includes many of the longest-established and most well-known brands on the European bathroom fixtures market, including its ‘‘national jewels’’: Ifö® (Sweden and Denmark), Ido® (Finland and Sweden), Keramag® (Germany), Sphinx® (the Netherlands), Twyford® (United Kingdom), Allia® (France), Pozzi-Ginori® (Italy), Kolo® (Poland) and Colombo® (Ukraine). In 2012, Sanitec’s net sales amounted to EUR 752.8 million and the number of employees amounted to approximately 6,500.  

Vinge’s team consisted mainly of Peter Bäärnhielm and David Andersson.

Related

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025

Vinge advises Advania in connection with the acquisition of atNorth HPC AB

Vinge has advised Advania, one of the leading IT companies in the Nordic region, in connection with the acquisition of atNorth HPC AB. The acquisition strengthens Advania's presence within high-performance computing (HPC).
October 03, 2025